登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《IJAA，3月12日，New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-13

  • New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

    Christian A.Devaux, Jean-MarcRolain, PhilippeColson, DidierRaoult

    Show more

    https://doi.org/10.1016/j.ijantimicag.2020.105938

    Abstract

    Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have since focused on rapid diagnosis and isolation of patients as well as the search for therapies able to counter the most severe effects of the disease.

  • 原文来源：https://www.sciencedirect.com/science/article/pii/S0924857920300881
42浏览量
原文链接
相关报告

  • 《IJAA，3月13日，Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-16
    • Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? Sophie AlexandraBaron, ChristianDevaux, PhilippeColson, DidierRaoult, Jean-MarcRolain Show more https://doi.org/10.1016/j.ijantimicag.2020.105944 Abstract In December 2019, a new coronavirus, named SARS-CoV-2, has emerged from China causing pneumonia outbreaks first in the Wuhan region and have now spread worldwide because of its probable high transmission efficiency. Due to the lack of efficient and specific treatments and the need to contain the epidemic, drug repurposing appears to be the best tool to find therapeutic solution. Chloroquine, remdesivir, lopinavir, ribavirin or ritonavir have shown efficacy to inhibit coronavirus in vitro.
    68浏览量
    原文链接

  • 《JAMA，3月13日，What Does the Coronavirus Disease 2019 (COVID-19) Mean for Families?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-14
    • What Does the Coronavirus Disease 2019 (COVID-19) Mean for Families? Lindsay A. Thompson, MD, MS1,2; Sonja A. Rasmussen, MD, MS1,3 JAMA Pediatr. Published online March 13, 2020. doi:10.1001/jamapediatrics.2020.0828 A new viral illness called coronavirus disease 2019 (COVID-19) was discovered in China in December 2019. Lessons learned from China and similar viral diseases can help families prepare for spread in the US. How children in the US will be affected is still mostly unknown. So far, proportionately fewer children have gotten sick in China, and the effects on them have mostly been mild. It is important for families to prepare for spread in the US. Who Is at Risk? COVID-19 appears to be spread via respiratory secretions when infected people cough or sneeze, similar to how influenza (flu) spreads. Currently, people at risk for COVID-19 include those who have been in close contact with infected people within 14 days before their symptoms began. The average time from when persons are exposed to signs of illness is about 5 days and can range from 2 to 14 days. People with COVID-19 have fever, cough, muscle aches, headache, and diarrhea, which are all symptoms similar to other viral infections, such as the flu. People who need hospitalization usually have severe pneumonia. Currently, there are no treatments or vaccines available.
    26浏览量
    原文链接